Myeloid leukemia after cytotoxic therapy and other hematotoxins

J Toxicol Environ Health A. 2000 Nov;61(5-6):381-6. doi: 10.1080/00984100050166398.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acute Disease
  • Antineoplastic Agents, Alkylating / adverse effects
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Leukemia, Myeloid / chemically induced
  • Leukemia, Myeloid / etiology*
  • Leukemia, Myeloid / genetics
  • Neoplasms, Second Primary / chemically induced
  • Neoplasms, Second Primary / etiology*
  • Neoplasms, Second Primary / genetics
  • Radiotherapy / adverse effects
  • Topoisomerase II Inhibitors

Substances

  • Antineoplastic Agents, Alkylating
  • Enzyme Inhibitors
  • Topoisomerase II Inhibitors